Cognitive Therapy to Prevent Depressive Relapse in Adults

Current Opinion in Psychology
Jeffrey R Vittengl, Robin B Jarrett

Abstract

The high prevalence, frequent relapse, and recurrence of major depressive disorder (MDD) increase its personal and societal costs. Cognitive therapy (CT) aims to decrease depressive symptoms and prevent relapse/recurrence. We review prevention evidence for acute, continuation, and maintenance CTs for patients whose depression is active, remitted, and recovered, respectively. Evidence suggests that patients relapse less often after discontinuing acute phase CT versus discontinuing pharmacotherapy. Continuation CT further decreases relapse relative to inactive controls and similarly to active pharmacotherapy. Maintenance CT may decrease recurrence but needs rigorous evaluation. Post-acute CT's preventive effects appear greater for higher-risk patients (e.g., with residual depressive symptoms, unstable acute-phase treatment response, childhood trauma, more prior depressive episodes), although risks may vary by specific CTs.

References

Aug 18, 1989·JAMA : the Journal of the American Medical Association·K B WellsJ Ware
Nov 28, 1997·The British Journal of Psychiatry : the Journal of Mental Science·I M Blackburn, R G Moore
Feb 15, 2000·The American Journal of Psychiatry·D A SolomonJ Endicott
Jun 14, 2002·Journal of Affective Disorders·F AngstJ Angst
Nov 27, 2002·The American Journal of Psychiatry·Giovanni A FavaSilvana Grandi
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giovanni Andrea FavaNicoletta Sonino
Apr 6, 2005·Archives of General Psychiatry·Steven D HollonRobert Gallop
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Apr 24, 2007·Clinical Psychology Review·Stephanie L Burcusa, William G Iacono
May 19, 2007·Journal of Affective Disorders·T Michael KashnerRobin B Jarrett
Jun 15, 2007·Journal of Consulting and Clinical Psychology·Jeffrey R VittenglRobin B Jarrett
Mar 25, 2008·Journal of Affective Disorders·Robin B JarrettLee Anna Clark
Feb 10, 2010·The Journal of Clinical Psychiatry·Claudi L H BocktingUNKNOWN DELTA Study Group
Mar 31, 2010·Journal of Consulting and Clinical Psychology·L Esther de GraafMarcus J H Huibers
Oct 19, 2010·Journal of Affective Disorders·Wendy Thomson
Mar 16, 2011·Acta Psychiatrica Scandinavica·F HolländareI Engström
Oct 25, 2011·Clinical Psychology Review·Shadi BeshaiLeanne Quigley
Sep 12, 2013·Behaviour Research and Therapy·Fredrik HolländareIngemar Engström
Dec 4, 2013·Journal of Consulting and Clinical Psychology·J Mark G WilliamsIan T Russell
Jan 10, 2014·Archives of Women's Mental Health·Angela J InglisJehannine C Austin
Apr 1, 2014·Journal of Affective Disorders·Pim CuijpersAnnemieke van Straten
Jul 22, 2014·Journal of Consulting and Clinical Psychology·Jeffrey R VittenglRobin B Jarrett
Jan 2, 2015·Journal of Affective Disorders·Karolien E M Biesheuvel-LeliefeldFilip Smit

❮ Previous
Next ❯

Citations

Feb 13, 2016·Zeitschrift für Gerontologie und Geriatrie·Dirk K Wolter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.